Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omicron BA.2 (B.1.1.529.2): high potential to becoming the next dominating variant
Jiahui Chen, Guo‐Wei Wei
Research Square (Research Square) (2022)
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines
John E. Bowen, Kaitlin R. Sprouse, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 42
Unraveling the dynamics of the Omicron and Delta variants of the 2019 coronavirus in the presence of vaccination, mask usage, and antiviral treatment
Calistus N. Ngonghala, Hémaho B. Taboe, Salman Safdar, et al.
Applied Mathematical Modelling (2022) Vol. 114, pp. 447-465
Open Access | Times Cited: 42
Omicron – The new SARS‐CoV‐2 challenge?
Alexandra Lino, Marita A. Cardoso, Paula Martins‐Lopes, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 4
Open Access | Times Cited: 39
Health Beliefs and Socioeconomic Determinants of COVID-19 Booster Vaccine Acceptance: An Indonesian Cross-Sectional Study
Gede Benny Setia Wirawan, Ngakan Putu Anom Harjana, Nur Wulan Nugrahani, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 724-724
Open Access | Times Cited: 37
Selective Pressure and Evolution of SARS-CoV-2 Lineages BF.7 and BQ.1.1 Circulating in Italy from July to December 2022
Alessandra Lo Presti, Luigina Ambrosio, Angela Di Martino, et al.
Microorganisms (2024) Vol. 12, Iss. 5, pp. 908-908
Open Access | Times Cited: 7
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 32
The Omicron (B.1.1.529) SARS-CoV-2 variant of concern also affects companion animals
Lidia Sánchez‐Morales, José Manuel Sánchez‐Vizcaíno, Marta Pérez‐Sancho, et al.
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 29
The SARS‐CoV‐2 Omicron Variant and its Multiple Sub‐lineages: Transmissibility, Vaccine Development, Antiviral Drugs, Monoclonal Antibodies, and Strategies for Infection Control – a Review
Ranjan K. Mohapatra, Sarika Verma, Venkataramana Kandi, et al.
ChemistrySelect (2023) Vol. 8, Iss. 9
Open Access | Times Cited: 16
Emerging SARS-CoV-2 Variants and Subvariants: Challenges and Opportunities in the Context of COVID-19 Pandemic
Smaranika Rahman, Md. Jamal Hossain, Zabun Nahar, et al.
Environmental Health Insights (2022) Vol. 16
Open Access | Times Cited: 24
Explosive outbreak of SARS-CoV-2 Omicron variant is associated with vertical transmission in high-rise residential buildings in Hong Kong
Vincent Chi‐Chung Cheng, Shuk‐Ching Wong, Albert Ka-Wing Au, et al.
Building and Environment (2022) Vol. 221, pp. 109323-109323
Open Access | Times Cited: 22
BA.1, BA.2 and BA.2.75 variants show comparable replication kinetics, reduced impact on epithelial barrier and elicit cross-neutralizing antibodies
Janmejay Singh, Anbalagan Anantharaj, Aleksha Panwar, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 2, pp. e1011196-e1011196
Open Access | Times Cited: 14
Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?
Abdul Hawil Abas, Siti Marfuah, Rinaldi Idroes, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2221-2221
Open Access | Times Cited: 19
Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic
Hari N. Krishnakumar, David Momtaz, Anusha Sherwani, et al.
European Archives of Oto-Rhino-Laryngology (2022) Vol. 280, Iss. 2, pp. 505-509
Open Access | Times Cited: 19
Genomic surveillance of SARS-CoV-2 in COVID-19 vaccinated healthcare workers in Lebanon
Habib Alkalamouni, Farouk F. Abou Hassan, Mirna Bou Hamdan, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Characterization of SARS-CoV-2 Variants in Military and Civilian Personnel of an Air Force Airport during Three Pandemic Waves in Italy
Michele Equestre, Cinzia Marcantonio, Nadia Marascio, et al.
Microorganisms (2023) Vol. 11, Iss. 11, pp. 2711-2711
Open Access | Times Cited: 10
Omicron BA.2 lineage predominance in severe acute respiratory syndrome coronavirus 2 positive cases during the third wave in North India
Kamran Zaman, Anita M. Shete, Shailendra Kumar Mishra, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 14
How Do Point Mutations Enhancing the Basic Character of the RBDs of SARS-CoV-2 Variants Affect Their Transmissibility and Infectivity Capacities?
Annick Barre, Bernard Klonjkowski, Hervé Benoist, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 783-783
Open Access | Times Cited: 13
Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths
Miguel Á. Ortega, Cielo García‐Montero, Óscar Fraile-Martínez, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 995-995
Open Access | Times Cited: 11
Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery
Gianmarco Stati, Paolo Amerio, Mario Nubile, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1404-1404
Open Access | Times Cited: 6
Structural Basis for the Enhanced Infectivity and Immune Evasion of Omicron Subvariants
Yaning Li, Yaping Shen, Yuanyuan Zhang, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1398-1398
Open Access | Times Cited: 6
Computational Investigation of Selected Spike Protein Mutations in SARS-CoV-2: Delta, Omicron, and Some Circulating Subvariants
Urmi Roy
Pathogens (2023) Vol. 13, Iss. 1, pp. 10-10
Open Access | Times Cited: 6
Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients
Florentino Villanego, Auxiliadora Mazuecos, Beatriz Rodríguez Cubillo, et al.
Clinical Kidney Journal (2022) Vol. 15, Iss. 10, pp. 1847-1855
Open Access | Times Cited: 10
A Glimpse on the Evolution of RNA Viruses: Implications and Lessons from SARS-CoV-2
Petra Šimičić, Snježana Židovec Lepej
Viruses (2022) Vol. 15, Iss. 1, pp. 1-1
Open Access | Times Cited: 10
Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January–March 2022
Daniela Loconsole, Francesca Centrone, Anna Sallustio, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 674-674
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top